Nia Therapeutics

medical devices

About

Nia Therapeutics is a neurotechnology company dedicated to developing an implanted neurostimulation therapy aimed at treating memory loss caused by traumatic brain injury (TBI) and other memory disorders. The company’s innovative approach features a personalized, closed-loop brain-computer interface (BCI) that monitors brain activity and delivers tailored electrical stimulation to enhance memory function when needed. Founded in 2018 by Dr. Michael Kahana and Dr. Daniel Rizzuto, Nia Therapeutics builds on research initially funded by the U.S. Department of Defense. Their flagship product continuously listens to brain signals and applies targeted stimulation during memory loss episodes. The therapy utilizes AI algorithms to personalize treatment based on individual brain data, with plans to expand its applications to neurodegenerative diseases and dementia. The company is also preparing for clinical trials to validate the safety and efficacy of its therapies, with enrollment expected to begin in 2026.

Technologies

GmailGoogle AppsGoogle Cloud HostingWordPress.orgreCAPTCHAMobile FriendlyAndroidIoTRemoteAIData Analytics

Keywords

medical equipment manufacturingneural implantai-driven therapy optimizationbiotechnologymemory loss treatmentmedical devicesneural sensing technologybrain signal classificationmemory encoding detectionbrain network regulationservicescloud ai systemtraumatic brain injuryneurostimulation therapybrain-computer interfaceclosed-loop stimulationbrain activity patternsbrain signals decodingai-guided neurostimulationbrain activity monitoringhealthcarememory network rescueb2bpersonalized brain stimulationpersonalized neurostimulationelectrical stimulationmedical equipment and supplies manufacturinghealthcare technologyhospital & health carehealth care

Location

Boston, Massachusetts, United States, 02115

Related Companies

Companies in the same industry